EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Deep Learning-Guided Discovery of Dual Inhibitors of SARS-CoV-2 Entry and 3CL Protease

Peng Gao iD, Ivan Pavlinov, Miao Xu, Catherine Z Chen iD, Desarey Morales Vasquez iD, Qi Zhang, Yihong Ye, Luis Martinez-Sobrido iD, Wei Zheng iD, Min Shen iD

Molecules · 20.03.2026 · 31 (6) · 1043

DOI: 10.3390/molecules31061043 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Molecules, online erschienen am 20.03.2026. Verfasst von Peng Gao und 9 weiteren Autor:innen. Beteiligte Einrichtung: Therapeutics Development Branch, Division of Preclinical Innovation, National Center for Translational Sciences (NCATS), National Institutes of Healt…. Hauptthemen laut MEDLINE: SARS-CoV-2, Antiviral Agents, Virus Internalization, Deep Learning. Die Arbeit nennt 65 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NCATS NIH HHS, National Center for Advancing Translational Sciences.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The rapid evolution of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) underscores the need for antivirals that are resilient to resistance. Current Food and Drug Administration (FDA)-approved therapies primarily target single viral mechanisms, leaving gaps in efficacy. Here, we developed a Deep Learning-based Activity Screening Model (DLASM), which integrates graph convolutional network with machine learning to identify SARS-CoV-2 inhibitors, using experimental 3-chymotrypsin-like (3CL) main protease assay data. The optimized DLASMs virtually screened ~170,000 compounds from diverse in-house collections and yielded novel hits, several of which not only inhibited the 3CL protease but also blocked viral entry by interfering with heparan sulfate-mediated host interactions. These activities were validated through multiple assays, including 3CL enzymatic inhibition, SARS-CoV-2 pseudotyped particle entry, α-synuclein fibril uptake as a proxy for endocytosis, live virus cytopathic effect, heparan sulfate-dependent entry assay, and a 3D human lung mucociliary tissue model. Molecular docking studies elucidated binding modes at the 3CL protease active site, while molecular dynamics simulations provided insights into compound–heparan sulfate interactions. The identified compounds represent early-stage hits with moderate potency that demonstrate dual-mechanism antiviral activity. Together, these findings establish dual-target inhibition as a promising antiviral strategy, offering not only enhanced potency but also reduced risk of resistance. Moreover, our DLASM framework provides a generalizable pipeline for identifying chemically diverse scaffolds and for broader applications beyond SARS-CoV-2.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

SARS-CoV-2Antiviral AgentsVirus InternalizationDeep LearningCoronavirus 3C ProteasesProtease InhibitorsCOVID-19 Drug TreatmentHumansMolecular Docking SimulationMolecular Dynamics SimulationDrug DiscoveryGraph Neural NetworksHeparan Sulfate

Stichwörter der Autor:innen

3CL proteaseSARS-CoV-2antiviral drug discoverydeep learning-based activity screening modeldual-target inhibitiongraph convolutional networksheparan sulfate

Substanzen

Antiviral AgentsCoronavirus 3C ProteasesProtease Inhibitors3C-like proteinase, SARS-CoV-2Heparan Sulfate

Autor:innen und Institutionen

  • Therapeutics Development Branch, Division of Preclinical Innovation, National Center for Translational Sciences (NCATS), National Institutes of Health (NIH), Rockville, MD 20850, USA.
  • Texas Biomedical Research Institute, San Antonio, TX 78227, USA.
  • National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), National Institutes of Health (NIH), Bethesda, MD 20892, USA.
  • Early Translation Branch, Division of Preclinical Innovation, National Center for Translational Sciences (NCATS), National Institutes of Health (NIH), Rockville, MD 20850, USA.

ORCID-Profile: Peng Gao, Catherine Z Chen, Desarey Morales Vasquez, Luis Martinez-Sobrido, Wei Zheng, Min Shen

Förderung

  • NCATS NIH HHS
  • National Center for Advancing Translational Sciences

Zitieren

APA

Gao, P., Pavlinov, I., Xu, M., Chen, C. Z., Morales Vasquez, D., Zhang, Q., Ye, Y., Martinez-Sobrido, L., Zheng, W., & Shen, M. (2026). Deep Learning-Guided Discovery of Dual Inhibitors of SARS-CoV-2 Entry and 3CL Protease. Molecules, 31(6), 1043. https://doi.org/10.3390/molecules31061043

Vancouver

Gao P, Pavlinov I, Xu M, Chen CZ, Morales Vasquez D, Zhang Q, et al. Deep Learning-Guided Discovery of Dual Inhibitors of SARS-CoV-2 Entry and 3CL Protease. Molecules. 2026;31(6):1043. doi:10.3390/molecules31061043

BibTeX
@article{Gao2026,
  author = {Gao, Peng and Pavlinov, Ivan and Xu, Miao and Chen, Catherine Z and Morales Vasquez, Desarey and Zhang, Qi and Ye, Yihong and Martinez-Sobrido, Luis and Zheng, Wei and Shen, Min},
  title = {Deep Learning-Guided Discovery of Dual Inhibitors of SARS-CoV-2 Entry and 3CL Protease},
  journal = {Molecules},
  year = {2026},
  volume = {31},
  number = {6},
  pages = {1043},
  doi = {10.3390/molecules31061043}
}
Kostenlos starten →